Published in Neuroscience on March 01, 1999
Dopamine in motivational control: rewarding, aversive, and alerting. Neuron (2010) 6.26
Discrete neurochemical coding of distinguishable motivational processes: insights from nucleus accumbens control of feeding. Psychopharmacology (Berl) (2007) 2.33
Food reinforcement and eating: a multilevel analysis. Psychol Bull (2007) 2.32
Human pavlovian-instrumental transfer. J Neurosci (2008) 2.06
Role of brain dopamine in food reward and reinforcement. Philos Trans R Soc Lond B Biol Sci (2006) 2.03
Maternal high-fat diet alters methylation and gene expression of dopamine and opioid-related genes. Endocrinology (2010) 2.02
Limbic and cortical information processing in the nucleus accumbens. Trends Neurosci (2008) 1.73
Ghrelin increases intake of rewarding food in rodents. Addict Biol (2010) 1.61
Nigrostriatal rAAV-mediated GDNF overexpression induces robust weight loss in a rat model of age-related obesity. Mol Ther (2009) 1.52
Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective. Brain Res Rev (2007) 1.50
Nothing tastes as good as skinny feels: the neurobiology of anorexia nervosa. Trends Neurosci (2013) 1.50
The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment. Psychopharmacology (Berl) (2003) 1.49
Simultaneous dopamine and single-unit recordings reveal accumbens GABAergic responses: implications for intracranial self-stimulation. Proc Natl Acad Sci U S A (2005) 1.44
Dorsomedial prefrontal cortex contribution to behavioral and nucleus accumbens neuronal responses to incentive cues. J Neurosci (2008) 1.44
Differential neurochemical and behavioral adaptation to cocaine after response contingent and noncontingent exposure in the rat. Psychopharmacology (Berl) (2006) 1.42
A food predictive cue must be attributed with incentive salience for it to induce c-fos mRNA expression in cortico-striatal-thalamic brain regions. Neuroscience (2011) 1.41
Primary food reward and reward-predictive stimuli evoke different patterns of phasic dopamine signaling throughout the striatum. Eur J Neurosci (2011) 1.36
D2 dopamine receptor Taq1A polymorphism, body weight, and dietary intake in type 2 diabetes. Nutrition (2008) 1.35
Rapid dopamine dynamics in the accumbens core and shell: learning and action. Front Biosci (Elite Ed) (2013) 1.34
The nucleus accumbens and Pavlovian reward learning. Neuroscientist (2007) 1.33
The contribution of brain reward circuits to the obesity epidemic. Neurosci Biobehav Rev (2012) 1.30
Brain-derived neurotrophic factor regulates hedonic feeding by acting on the mesolimbic dopamine system. J Neurosci (2010) 1.30
Depressive-like effects of the kappa opioid receptor agonist salvinorin A are associated with decreased phasic dopamine release in the nucleus accumbens. Psychopharmacology (Berl) (2010) 1.24
Metabolic hormones, dopamine circuits, and feeding. Front Neuroendocrinol (2009) 1.22
The shell of the nucleus accumbens has a higher dopamine response compared with the core after non-contingent intravenous ethanol administration. Neuroscience (2008) 1.15
Encoding of aversion by dopamine and the nucleus accumbens. Front Neurosci (2012) 1.13
The dopamine response in the nucleus accumbens core-shell border differs from that in the core and shell during operant ethanol self-administration. Alcohol Clin Exp Res (2009) 1.09
Reduced nucleus accumbens and caudate nucleus activation to a pleasant taste is associated with obesity in older adults. Brain Res (2011) 1.08
Cue-elicited reward-seeking requires extracellular signal-regulated kinase activation in the nucleus accumbens. J Neurosci (2008) 1.08
Ghrelin acts as an interface between physiological state and phasic dopamine signaling. J Neurosci (2014) 1.07
Differential impact of pavlovian drug conditioned stimuli on in vivo dopamine transmission in the rat accumbens shell and core and in the prefrontal cortex. Psychopharmacology (Berl) (2006) 1.05
Dual roles of dopamine in food and drug seeking: the drive-reward paradox. Biol Psychiatry (2012) 1.03
Differential dopamine release dynamics in the nucleus accumbens core and shell track distinct aspects of goal-directed behavior for sucrose. Neuropharmacology (2012) 1.02
Differences in response to food stimuli in a rat model of obesity: in-vivo assessment of brain glucose metabolism. Int J Obes (Lond) (2008) 1.02
Palatable meal anticipation in mice. PLoS One (2010) 1.02
Taste uncoupled from nutrition fails to sustain the reinforcing properties of food. Eur J Neurosci (2012) 1.02
Diet choice, cortisol reactivity, and emotional feeding in socially housed rhesus monkeys. Physiol Behav (2010) 1.00
Defining the caudal ventral striatum in primates: cellular and histochemical features. J Neurosci (2002) 0.99
Reciprocal effects of response contingent and noncontingent intravenous heroin on in vivo nucleus accumbens shell versus core dopamine in the rat: a repeated sampling microdialysis study. Psychopharmacology (Berl) (2007) 0.99
Does a shared neurobiology for foods and drugs of abuse contribute to extremes of food ingestion in anorexia and bulimia nervosa? Biol Psychiatry (2013) 0.98
Control of within-binge cocaine-seeking by dopamine and glutamate in the core of nucleus accumbens. Psychopharmacology (Berl) (2009) 0.98
Withdrawal from free-choice high-fat high-sugar diet induces craving only in obesity-prone animals. Psychopharmacology (Berl) (2009) 0.98
Amygdaloid inputs define a caudal component of the ventral striatum in primates. J Comp Neurol (2004) 0.97
Compulsivity in anorexia nervosa: a transdiagnostic concept. Front Psychol (2014) 0.95
Preferential increase of extracellular dopamine in the rat nucleus accumbens shell as compared to that in the core during acquisition and maintenance of intravenous nicotine self-administration. Psychopharmacology (Berl) (2006) 0.95
Role of amygdala dopamine D1 and D2 receptors in the acquisition and expression of fructose-conditioned flavor preferences in rats. Behav Brain Res (2009) 0.94
Effects of dopamine antagonists on drug cue-induced reinstatement of nicotine-seeking behavior in rats. Behav Pharmacol (2010) 0.91
Glucagon-like peptide-1 receptor activation in the nucleus accumbens core suppresses feeding by increasing glutamatergic AMPA/kainate signaling. J Neurosci (2014) 0.91
Prolonged high fat diet reduces dopamine reuptake without altering DAT gene expression. PLoS One (2013) 0.91
Amphetamine induced dopamine release increases anxiety in individuals recovered from anorexia nervosa. Int J Eat Disord (2011) 0.91
Basal ganglia circuit loops, dopamine and motivation: A review and enquiry. Behav Brain Res (2015) 0.90
Comparative genetics of the central nervous system in epigean and hypogean Astyanax mexicanus. Genetica (2011) 0.90
Intact discrimination reversal learning but slowed responding to reward-predictive cues after dopamine D1 and D2 receptor blockade in the nucleus accumbens of rats. Psychopharmacology (Berl) (2006) 0.90
Food scarcity, neuroadaptations, and the pathogenic potential of dieting in an unnatural ecology: binge eating and drug abuse. Physiol Behav (2011) 0.90
Addictive genes and the relationship to obesity and inflammation. Mol Neurobiol (2011) 0.89
Stress and eating: a dual role for bombesin-like peptides. Front Neurosci (2013) 0.88
Altered feeding and body weight following melanocortin administration to the ventral tegmental area in adult rats. Psychopharmacology (Berl) (2012) 0.88
Interactions between genotype and depressive symptoms on obesity. Behav Genet (2009) 0.87
Varenicline decreases ethanol intake and increases dopamine release via neuronal nicotinic acetylcholine receptors in the nucleus accumbens. Br J Pharmacol (2014) 0.87
Changes in nucleus accumbens and neostriatal c-Fos and DARPP-32 immunoreactivity during different stages of food-reinforced instrumental training. Eur J Neurosci (2012) 0.86
Reciprocal responsiveness of nucleus accumbens shell and core dopamine to food- and drug-conditioned stimuli. Psychopharmacology (Berl) (2010) 0.86
Heterogeneity of dopamine neuron activity across traits and states. Neuroscience (2014) 0.86
Changes in feeding and locomotion induced by amphetamine analogs in rats. Drug Alcohol Depend (2008) 0.86
Social stress interacts with diet history to promote emotional feeding in females. Psychoneuroendocrinology (2012) 0.85
The neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humans. Subst Abuse Rehabil (2013) 0.85
The adenosine A2A receptor agonist, CGS-21680, blocks excessive rearing, acquisition of wheel running, and increases nucleus accumbens CREB phosphorylation in chronically food-restricted rats. Brain Res (2007) 0.85
Amylin modulates the mesolimbic dopamine system to control energy balance. Neuropsychopharmacology (2014) 0.84
Attention-deficit/hyperactivity disorder: is it time to reappraise the role of sugar consumption? Postgrad Med (2011) 0.84
Natural addiction: a behavioral and circuit model based on sugar addiction in rats. J Addict Med (2009) 0.84
Real-time dopamine efflux in the nucleus accumbens core during Pavlovian conditioning. Behav Neurosci (2008) 0.83
A preliminary study of the human brain response to oral sucrose and its association with recent drinking. Alcohol Clin Exp Res (2013) 0.82
High locomotor reactivity to novelty is associated with an increased propensity to choose saccharin over cocaine: new insights into the vulnerability to addiction. Neuropsychopharmacology (2014) 0.79
Decreased consumption of rewarding sucrose solutions after injection of melanocortins into the ventral tegmental area of rats. Psychopharmacology (Berl) (2014) 0.79
Oestradiol differentially influences feeding behaviour depending on diet composition in female rhesus monkeys. J Neuroendocrinol (2013) 0.78
Effects of ICV administration of the alpha1A-adrenoceptor antagonist 5-methylurapidil on concurrent measures of eating and locomotion after cocaine in the rat. Life Sci (2007) 0.78
Extinction and reinstatement of phasic dopamine signals in the nucleus accumbens core during Pavlovian conditioning. Behav Neurosci (2014) 0.78
Safety out of control: dopamine and defence. Behav Brain Funct (2016) 0.77
Episodic sucrose intake during food restriction increases synaptic abundance of AMPA receptors in nucleus accumbens and augments intake of sucrose following restoration of ad libitum feeding. Neuroscience (2015) 0.77
Integration of reward signalling and appetite regulating peptide systems in the control of food-cue responses. Br J Pharmacol (2015) 0.77
Stress exposure, food intake and emotional state. Stress (2015) 0.77
Relationship of Dopamine of the Nucleus Accumbens with Intra-infralimbic Apomorphine Microinjection. Iran J Basic Med Sci (2013) 0.77
Algorithms for survival: a comparative perspective on emotions. Nat Rev Neurosci (2017) 0.76
The Influence of Palatable Diets in Reward System Activation: A Mini Review. Adv Pharmacol Sci (2016) 0.76
Appetitive cue-evoked ERK signaling in the nucleus accumbens requires NMDA and D1 dopamine receptor activation and regulates CREB phosphorylation. Learn Mem (2014) 0.76
Food restriction dissociates sexual motivation, sexual performance, and the rewarding consequences of copulation in female Syrian hamsters. Behav Brain Res (2011) 0.76
Understanding the control of ingestive behavior in primates. Horm Behav (2014) 0.76
The ketamine-like compound methoxetamine substitutes for ketamine in the self-administration paradigm and enhances mesolimbic dopaminergic transmission. Psychopharmacology (Berl) (2016) 0.76
Further delineation between typical and atypical dopamine uptake inhibitors: effects on food-maintained behavior and food consumption. Behav Pharmacol (2016) 0.75
Reassessing wanting and liking in the study of mesolimbic influence on food intake. Am J Physiol Regul Integr Comp Physiol (2016) 0.75
Changes in Dopamine Transmission in the Nucleus Accumbens Shell and Core during Ethanol and Sucrose Self-Administration. Front Behav Neurosci (2017) 0.75
High-fat diet alters the dopamine and opioid systems: effects across development. Int J Obes Suppl (2012) 0.75
Glutamate and Opioid Antagonists Modulate Dopamine Levels Evoked by Innately Attractive Male Chemosignals in the Nucleus Accumbens of Female Rats. Front Neuroanat (2017) 0.75
Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature (1996) 4.52
Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science (1997) 3.77
Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc Natl Acad Sci U S A (1995) 2.66
Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. J Pharmacol Exp Ther (1986) 2.30
Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur J Pharmacol (1986) 1.73
Differential influence of associative and nonassociative learning mechanisms on the responsiveness of prefrontal and accumbal dopamine transmission to food stimuli in rats fed ad libitum. J Neurosci (1997) 1.61
Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J Neurochem (1990) 1.51
Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience (1989) 1.49
Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene. J Neurosci (2001) 1.40
Modulation of feeding-induced activation of mesolimbic dopamine transmission by appetitive stimuli and its relation to motivational state. Eur J Neurosci (1999) 1.38
Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis. J Neurosci (1985) 1.31
A dopamine-mu1 opioid link in the rat ventral tegmentum shared by palatable food (Fonzies) and non-psychostimulant drugs of abuse. Eur J Neurosci (1998) 1.26
Stimulation of in vivo dopamine transmission in the bed nucleus of stria terminalis by reinforcing drugs. J Neurosci (2000) 1.23
Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine. Eur J Neurosci (1997) 1.15
Differential inhibitory effects of a 5-HT3 antagonist on drug-induced stimulation of dopamine release. Eur J Pharmacol (1989) 1.14
Self-inhibitory dopamine receptors: their role in the biochemical and behavioral effects of low doses of apomorphine. Adv Biochem Psychopharmacol (1978) 1.12
Psychostimulant sensitization: differential changes in accumbal shell and core dopamine. Eur J Pharmacol (2000) 1.12
A role for dopamine D1 receptors of the nucleus accumbens shell in conditioned taste aversion learning. J Neurosci (2001) 1.11
Profound depression of mesolimbic dopamine release after morphine withdrawal in dependent rats. Eur J Pharmacol (1991) 1.10
Depression of mesolimbic dopamine transmission and sensitization to morphine during opiate abstinence. J Neurochem (1992) 1.08
Noradrenaline transporter blockers raise extracellular dopamine in medial prefrontal but not parietal and occipital cortex: differences with mianserin and clozapine. J Neurochem (2004) 1.08
Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential? Psychopharmacology (Berl) (1994) 1.06
Ethanol preferentially stimulates dopamine release in the nucleus accumbens of freely moving rats. Eur J Pharmacol (1985) 1.05
Behavioural sensitization after repeated exposure to Delta 9-tetrahydrocannabinol and cross-sensitization with morphine. Psychopharmacology (Berl) (2001) 1.05
Differential changes in accumbens shell and core dopamine in behavioral sensitization to nicotine. Eur J Pharmacol (2000) 1.04
Evidence for dopamine receptors mediating sedation in the mouse brain. Nature (1976) 1.02
Preferential stimulation of dopamine release in the nucleus accumbens by opiates, alcohol, and barbiturates: studies with transcerebral dialysis in freely moving rats. Ann N Y Acad Sci (1986) 1.00
Cannabinoid CB(1) receptor agonists increase rat cortical and hippocampal acetylcholine release in vivo. Eur J Pharmacol (2000) 0.97
Mu opioid receptor signaling in morphine sensitization. Neuroscience (2003) 0.96
SCH 23390 blocks drug-conditioned place-preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade? Psychopharmacology (Berl) (1989) 0.96
Evidence for a GABAergic projection from the substantia nigra to the ventromedial thalamus and to the superior colliculus of the rat. Brain Res (1979) 0.94
Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW373U86 and SNC 80: 2. Place-preference and brain microdialysis studies in rats. Behav Pharmacol (1998) 0.94
Decrease in basal dopamine levels in the nucleus accumbens shell during daily drug-seeking behaviour in rats. Brain Res (2002) 0.93
Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW373U86 and SNC 80: 1. Locomotion, rearing and stereotypies in intact rats. Behav Pharmacol (1998) 0.93
(D-Ala2)deltorphin II: D1-dependent stereotypies and stimulation of dopamine release in the nucleus accumbens. J Neurosci (1991) 0.92
Dissociation of physical abstinence signs from changes in extracellular dopamine in the nucleus accumbens and in the prefrontal cortex of nicotine dependent rats. Drug Alcohol Depend (2000) 0.92
Mianserin markedly and selectively increases extracellular dopamine in the prefrontal cortex as compared to the nucleus accumbens of the rat. Psychopharmacology (Berl) (1996) 0.91
Reciprocal changes in dopamine responsiveness in the nucleus accumbens shell and core and in the dorsal caudate-putamen in rats sensitized to morphine. Neuroscience (1999) 0.91
Non-psychostimulant drugs of abuse and anxiogenic drugs activate with differential selectivity dopamine transmission in the nucleus accumbens and in the medial prefrontal cortex of the rat. Psychopharmacology (Berl) (1996) 0.90
Serotonin release estimated by transcortical dialysis in freely-moving rats. Neuroscience (1989) 0.90
Dependence of mesolimbic dopamine transmission on delta9-tetrahydrocannabinol. Eur J Pharmacol (1999) 0.89
Postsynaptic receptors are not essential for dopaminergic feedback regulation. Nature (1977) 0.89
Extracellular concentrations of dopamine and metabolites in the rat caudate after oral administration of a novel catechol-O-methyltransferase inhibitor Ro 40-7592. J Neurochem (1992) 0.89
5-HT3 receptor antagonists block morphine- and nicotine-induced place-preference conditioning. Eur J Pharmacol (1988) 0.89
Caffeine and accumbens shell dopamine. J Neurochem (2007) 0.88
5HT3 receptor antagonists block morphine- and nicotine- but not amphetamine-induced reward. Psychopharmacology (Berl) (1989) 0.88
Cannabinoid facilitation of behavioral and biochemical hedonic taste responses. Neuropharmacology (2011) 0.87
Blockade of delta-opioid receptors in the nucleus accumbens prevents ethanol-induced stimulation of dopamine release. Eur J Pharmacol (1993) 0.87
Role of vesicular dopamine in the in vivo stimulation of striatal dopamine transmission by amphetamine: evidence from microdialysis and Fos immunohistochemistry. Neuroscience (1995) 0.87
Differential roles of splanchnic and peripheral tissues in determining diurnal fluctuation of glucose tolerance. Am J Physiol (1989) 0.87
Time and dose dependence of the 'priming' of the expression of dopamine receptor supersensitivity. Eur J Pharmacol (1989) 0.85
Stereospecific blockade of N-methyl-D-aspartate transmission by MK 801 prevents priming of SKF 38393-induced turning. Psychopharmacology (Berl) (1990) 0.85
Adenosine A2 receptors stimulate c-fos expression in striatal neurons of 6-hydroxydopamine-lesioned rats. Neuroscience (1995) 0.84
Blockade of muscarinic receptors potentiates D1 dependent turning behavior and c-fos expression in 6-hydroxydopamine-lesioned rats but does not influence D2 mediated responses. Neuroscience (1993) 0.84
On the preferential release of mesolimbic dopamine by amphetamine. Neuropsychopharmacology (1991) 0.84
Intravenous administration of ecstasy (3,4-methylendioxymethamphetamine) enhances cortical and striatal acetylcholine release in vivo. Eur J Pharmacol (2001) 0.84
Increase of brain tryptophan by electroconvulsive shock in rats. J Neurochem (1972) 0.83
Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis. Eur J Pharmacol (1988) 0.83
Reduced dopamine in peripheral blood lymphocytes in Parkinson's disease. Neuroreport (1999) 0.82
Nucleus accumbens shell and core dopamine responsiveness to sucrose in rats: role of response contingency and discriminative/conditioned cues. Eur J Neurosci (2015) 0.82
Agonist-induced homologous and heterologous sensitization to D-1- and D-2-dependent contraversive turning. Eur J Pharmacol (1987) 0.82
Catalepsy induced by SCH 23390 in rats. Eur J Pharmacol (1985) 0.82
Chronic desipramine and fluoxetine differentially affect extracellular dopamine in the rat prefrontal cortex. Psychopharmacology (Berl) (1996) 0.82
Blockade of D-1 receptors by SCH 23390 antagonizes morphine- and amphetamine-induced place preference conditioning. Eur J Pharmacol (1987) 0.82
Evidence that methadone blocks dopamine receptors in the brain. J Neurochem (1972) 0.82
Adenosine A2 receptors interact negatively with dopamine D1 and D2 receptors in unilaterally 6-hydroxydopamine-lesioned rats. Eur J Pharmacol (1994) 0.81
Different sensitivity of in vivo acetylcholine transmission to D1 receptor stimulation in shell and core of nucleus accumbens. Neuroscience (1999) 0.81
Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats. J Pharmacol Exp Ther (1988) 0.81
Nigral dopamine autoreceptors are exclusively of the D2 type: quantitative autoradiography of [125I]iodosulpride and [125I]SCH 23982 in adjacent brain sections. Neuroscience (1988) 0.81
Antagonism of apomorphine-induced yawning by SCH 23390: evidence against the autoreceptor hypothesis. Psychopharmacology (Berl) (1986) 0.81
Local cerebral glucose utilization after D1 receptor stimulation in 6-OHDA lesioned rats: effect of sensitization (priming) with a dopaminergic agonist. Synapse (1993) 0.81
Delta9-tetrahydrocannabinol enhances cortical and hippocampal acetylcholine release in vivo: a microdialysis study. Eur J Pharmacol (2001) 0.80
Substantia nigra as a site of origin of dopamine-dependent motor syndromes induced by stimulation of mu and delta opioid receptors. Brain Res (1989) 0.80
Priming of rotational behavior by a dopamine receptor agonist in Hemiparkinsonian rats: movement-dependent induction. Neuroscience (2008) 0.80
Quantitative autoradiographical analysis of the age-related modulation of central dopamine D1 and D2 receptors. Neuroscience (1990) 0.80
5-HT3 receptors antagonists block morphine- and nicotine- but not amphetamine-induced place-preference conditioning. Pharmacol Res Commun (1988) 0.79
Differential role of dopamine in drug- and lithium-conditioned saccharin avoidance. Physiol Behav (2005) 0.79
Role of the parafascicular thalamic nucleus and N-methyl-D-aspartate transmission in the D1-dependent control of in vivo acetylcholine release in rat striatum. Neuroscience (1996) 0.79
Modulation of Delta(9)-THC-induced increase of cortical and hippocampal acetylcholine release by micro opioid and D(1) dopamine receptors. Neuropharmacology (2006) 0.79
Dopaminergic D-1 receptors: essential role in morphine-induced hypermotility. Psychopharmacology (Berl) (1987) 0.79
Cortical and limbic dopamine (on opiate addiction): do not mix before use! Trends Pharmacol Sci (1997) 0.79
Role of dorsal mesencephalic reticular formation and deep layers of superior colliculus as out-put stations for turning behaviour elicited from the substantia nigra pars reticulata. Brain Res (1981) 0.78
Role of dopamine D1 receptors in the control of striatal acetylcholine release by endogenous dopamine. Neurol Sci (2001) 0.78
Permissive role of D-1 receptor stimulation for the expression of D-2 mediated behavioral responses: a quantitative phenomenological study in rats. Life Sci (1987) 0.78
Haloperidol increases and apomorphine decreases striatal dopamine metabolism after destruction of striatal dopamine-sensitive adenylate cyclase by kainic acid. Brain Res (1977) 0.78
A microdialysis study of ST1936, a novel 5-HT6 receptor agonist. Neuropharmacology (2010) 0.78
Evidence that nigral GABA mediates behavioural responses elicited by striatal dopamine receptor stimulation. Life Sci (1978) 0.78
L-dopa stimulates c-fos expression in dopamine denervated striatum by combined activation of D-1 and D-2 receptors. Brain Res (1993) 0.78
Localization of nigral dopamine-sensitive adenylate cyclase on neurons originating from the corpus striatum. Science (1977) 0.78
Pharmacology and neurochemistry of apomorphine. Adv Pharmacol Chemother (1978) 0.78
Sleep induced by low doses of apomorphine in rats. Electroencephalogr Clin Neurophysiol (1979) 0.78
Evidence for a role of a dopamine/5-HT6 receptor interaction in cocaine reinforcement. Neuropharmacology (2012) 0.78
Increase of extracellular dopamine in the medial prefrontal cortex during spontaneous and naloxone-precipitated opiate abstinence. Psychopharmacology (Berl) (1995) 0.78
Calcium-dependent, tetrodotoxin-sensitive stimulation of cortical serotonin release after a tryptophan load. J Neurochem (1989) 0.78
Severe osteoporosis and multiple vertebral collapses in a child during treatment for B-ALL. Acta Haematol (1993) 0.78
Effects of cocaine and morphine in rats from two psychogenetically selected lines: a behavioral and brain dialysis study. Behav Genet (1997) 0.78
Opposite effects of NMDA receptor blockade on dopaminergic D1- and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression. J Pharmacol Exp Ther (1992) 0.77
A re-evaluation of the role of superior colliculus in turning behaviour. Brain Res (1982) 0.77
6-Hydroxydopamine lesions reduce specific [3H]sulpiride binding in the rat substantia nigra: direct evidence for the existence of nigral D-2 autoreceptors. Eur J Pharmacol (1987) 0.77